Expansion and Infrastructure Daiichi Sankyo Europe plans to invest approximately EUR 1 billion into transforming its facilities into a hub for innovation and manufacturing, indicating an opportunity to offer advanced manufacturing, logistics, and facility management solutions.

Digital Therapeutics Growth The company's recent launch of digital therapeutics in partnership with GAIA demonstrates a strategic shift towards digital health solutions, creating potential sales avenues for digital platform providers, health app developers, and remote monitoring technologies.

Research Collaborations Active collaborations with research institutions like BioMed X and participation in cancer therapy projects highlight opportunities to introduce innovative biotech tools, research equipment, and data analytics services aimed at advancing their R&D efforts.

Market Focus and Innovation Daiichi Sankyo’s emphasis on oncology and cardiovascular therapies, combined with efforts to set a customer-centric benchmark, presents a chance to deliver tailored medical devices, patient engagement platforms, and clinical support solutions tailored for these key therapeutic areas.

Sustainability & Facilities Recent expansion of manufacturing facilities, including the use of advanced cranes and construction projects, signals potential sales opportunities for industrial equipment, sustainability consulting, and smart building technologies aimed at enhancing operational efficiency.